XML 105 R86.htm IDEA: XBRL DOCUMENT
v3.20.2

Contingencies and Certain Commitments (Product Litigation, Commercial and Other Matters, Resolved Matters) (Details) $ in Millions | 1 Months Ended | 3 Months Ended
--- | --- | ---
Jul. 31, 2020 plaintiff | Oct. 31, 2018 manufacturer | Sep. 30, 2018 lagoon | Nov. 30, 2017 class_action | Mar. 31, 2013 lagoon | Jun. 28, 2020 USD ($) lawsuit
Loss Contingencies [Line Items] |  |  |  |  |  |
Number of class actions filed | class_action |  |  |  | 2 |  |
Hormone Therapy Products [Member] | Class Action Versus Wyeth [Member] | Settled Litigation [Member] |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |
Settlement agreed | $ |  |  |  |  |  | $ 200
Docetaxel [Member] | Pfizer And Hospira And Various Other Manufacturers Versus Mississippi Attorney General [Member] | Pending Litigation [Member] |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |
Number of defendants other than main defendant | manufacturer |  | 8 |  |  |  |
Environmental Remediation Litigation [Member] |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |
Number of lagoons | lagoon |  |  | 2 |  | 2 |
Minimum [Member] | EpiPen [Member] |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |
Number of lawsuits | lawsuit |  |  |  |  |  | 1
Subsequent Event [Member] | Patent Infringement [Member] | NHS Scotland vs. Dr Reddy's [Member] | Pending Litigation [Member] |  |  |  |  |  |
Loss Contingencies [Line Items] |  |  |  |  |  |
Number of plaintiffs | plaintiff | 14 |  |  |  |  |

X
- Definition Feasibility Study, Number Of Lagoons + References No definition available. + Details
Name: | pfe_FeasibilityStudyNumberOfLagoons
Namespace Prefix: | pfe_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Loss Contingency, Class Actions Filed, Number + References No definition available. + Details
Name: | pfe_LossContingencyClassActionsFiledNumber
Namespace Prefix: | pfe_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Loss Contingency, Number Of Defendants Other Than Main Defendant + References No definition available. + Details
Name: | pfe_LossContingencyNumberOfDefendantsOtherThanMainDefendant
Namespace Prefix: | pfe_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Loss Contingency, Number Of Lawsuits + References No definition available. + Details
Name: | pfe_LossContingencyNumberOfLawsuits
Namespace Prefix: | pfe_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_LossContingenciesLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of plaintiffs that have filed claims pertaining to a loss contingency. + References No definition available. + Details
Name: | us-gaap_LossContingencyNumberOfPlaintiffs
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of cash paid for the settlement of litigation or for other legal issues during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (g) -URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585 + Details
Name: | us-gaap_PaymentsForLegalSettlements
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_ProductOrServiceAxis=pfe_HormoneTherapyProductsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=pfe_ClassActionVersusWyethMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=pfe_DocetaxelMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=pfe_PfizerAndHospiraAndVariousOtherManufacturersVersusMississippiAttorneyGeneralMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LossContingenciesByNatureOfContingencyAxis=pfe_EnvironmentalRemediationLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=pfe_EpiPenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LossContingenciesByNatureOfContingencyAxis=pfe_PatentInfringementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_LitigationCaseAxis=pfe_NHSScotlandvs.DrReddysMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |